紐約，2026 年 4 月 27 日/PRNewswire/ -- Rowley Law PLLC 正在調查 XOMA Royalty Corporation (NASDAQ: XOMA) 及其董事會在與 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) 提議收購該公司的過程中可能存在的證券法違規行為。股東將獲得每股 XOMA Royalty 股票 39.00 美元和一項附帶價值權。該交易的估值約為 7.39 億美元，預計將在 2026 年第三季度完成。
如果您是 XOMA Royalty Corporation 的股東，並且對獲取有關此調查的更多信息感興趣，請訪問我們的網站：http://www.rowleylawpllc.com/investigation/xoma/。您也可以通過電子郵件聯繫 Rowley Law PLLC 的 Shane Rowley 律師，地址為 50 Main Street Suite 1000, White Plains, NY 10606，電子郵件為 [email protected]，或撥打電話 914-400-1920 或 844-400-4643（免費電話）。
Rowley Law PLLC 在全國範圍內代表股東參與複雜公司訴訟中的集體訴訟和衍生訴訟。有關該公司及其律師的更多信息，請訪問 http://www.rowleylawpllc.com。
律師廣告。之前的結果並不保證類似的結果。
來源 Rowley Law PLLC
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI3Jk5ld3NJdGVtSWQ9Tlk0NDM1MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjcxNTA2UFJfTkVXU19VU1BSX19fX19OWTQ0MzUx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI3Jk5ld3NJdGVtSWQ9Tlk0NDM1MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjcxNTA2UFJfTkVXU19VU1BSX19fX19OWTQ0MzUx"/>

標記臨牀研究

Rowley Law PLLC 正在調查 XOMA Royalty Corporation（納斯達克代碼：XOMA）及其董事會在 Ligand Pharmaceuticals Incorporated（納斯達克代碼：LGND）擬議收購中的潛在證券法違規行為。股東將每股獲得 39.00 美元和一個附帶價值權，該交易估值約為 7.39 億美元，預計將在 2026 年第三季度完成。感興趣的股東可以聯繫 Rowley Law PLLC 獲取更多信息

NEW YORK, April 27, 2026 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by XOMA Royalty Corporation (NASDAQ: XOMA) and its board of directors concerning the proposed acquisition of the company by Ligand Pharmaceuticals Incorporated (NASDAQ: LGND). Stockholders will receive $39.00 and one contingent value right for each share of XOMA Royalty stock that they hold. The transaction is valued at approximately $739 million and is expected to close in the third quarter of 2026.
<div class="lb-trans">紐約，2026 年 4 月 27 日/PRNewswire/ -- Rowley Law PLLC 正在調查 XOMA Royalty Corporation (NASDAQ: XOMA) 及其董事會在與 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) 提議收購該公司的過程中可能存在的證券法違規行為。股東將獲得每股 XOMA Royalty 股票 39.00 美元和一項附帶價值權。該交易的估值約為 7.39 億美元，預計將在 2026 年第三季度完成。
</div>If you are a stockholder of XOMA Royalty Corporation and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/xoma/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
<div class="lb-trans">如果您是 XOMA Royalty Corporation 的股東，並且對獲取有關此調查的更多信息感興趣，請訪問我們的網站：http://www.rowleylawpllc.com/investigation/xoma/。您也可以通過電子郵件聯繫 Rowley Law PLLC 的 Shane Rowley 律師，地址為 50 Main Street Suite 1000, White Plains, NY 10606，電子郵件為 [email protected]，或撥打電話 914-400-1920 或 844-400-4643（免費電話）。
</div>Rowley Law PLLC represents stockholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
<div class="lb-trans">Rowley Law PLLC 在全國範圍內代表股東參與複雜公司訴訟中的集體訴訟和衍生訴訟。有關該公司及其律師的更多信息，請訪問 http://www.rowleylawpllc.com。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律師廣告。之前的結果並不保證類似的結果。
</div>SOURCE Rowley Law PLLC
<div class="lb-trans">來源 Rowley Law PLLC
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI3Jk5ld3NJdGVtSWQ9Tlk0NDM1MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjcxNTA2UFJfTkVXU19VU1BSX19fX19OWTQ0MzUx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY44351&amp;Transmission_Id=202604271506PR_NEWS_USPR_____NY44351&amp;DateId=20260427"/>

15:06 ETALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation

15:06 ET 警報：Rowley Law PLLC 正在調查擬議收購標記臨牀研究公司的情況